The global clinical trial matching software market accounted for USD 168.3 million in 2023 and is expected to reach at USD 667.2 million by 2034 with a CAGR of 13.34% during the forecast period 2024-2034. Increasing occurrence of chronic diseases, rising demand for clinical trials, surge in the integration of advanced technology such as Electronic Data Capture (EDC) & clinical trials management systems, regulatory bodies granting approvals for novel products, growing need for clinical trial services from Contract Research Organizations (CROs) within the pharmaceutical industry, increasing inclination towards virtual or remote trials among pharmaceutical companies, research organizations, & hospitals, and rising introduction of sophisticated clinical trial matching software are some of the key factors boosting the market growth.
Rising introduction of sophisticated clinical trial matching software is predicted to boost the market growth during the forecast period. Pharmaceutical manufacturers, biotechnology firms, clinical research organizations (CROs), and medical device manufacturers frequently conduct clinical trials to assess the safety and efficacy of new drugs, diagnostics, and therapies. With patient recruitment and matching being essential components of clinical trials, there's a growing trend of conducting these trials in developing regions where such resources are readily available. For instance, in September 2023, Belong.Life has introduced a novel artificial intelligence (AI) platform for matching cancer clinical trials, named Tara. This Software as a Service (SaaS) solution is accessible to hospitals, health systems, and contract research organizations (CROs). In order to match patients with appropriate clinical trials based on their eligibility and geography, Tara uses machine learning and natural language processing.
By deployment mode, web & cloud was the highest revenue-grossing segment in the global clinical trial matching software market in 2023 owing to the cloud computing concept, which offers powerful cloud-based solutions and is easy to operate with no maintenance costs. Development expenses are decreased since internal server infrastructure is not needed. It may be accessible from anywhere and has a far shorter integration period. Sharing data is easy and enables cooperation on many initiatives. For instance, in July 2022, The Advarra eRegulatory Management (eReg) system now offers an end-to-end Secure Document Exchange solution. Leading provider of clinical research technologies for sponsors and sites, regulatory review systems, and consulting services for research quality and compliance is Advarra. Additionally, on-premises is predicted to grow at the fastest CAGR during the forecast period owing to the approach necessitates longer integration periods, in-house infrastructure, software license, and IT support. Government and financial institutions, among other organizations, need to ensure the security and privacy of their on-premises environment since they handle highly secret data.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global clinical trial matching software market in 2023 owing to the huge amount of clinical trials needed before a product is introduced. Additionally, contract research organization (CRO) is expected to grow at the fastest CAGR during the forecast period. Software providers are developing innovative, cutting-edge techniques, while CROs provide drug development through commercialization, pharmacovigilance, and post-approval services to industrial businesses with limited R&D funds. For instance, in February 2022, The CTMA made CT-SCOUT technology more accessible in the field of rheumatology.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing uptake of clinical trials matching software among pharmaceutical & biotechnology firms, rising investment in the development of such software, favorable regulatory landscape conducive to the development & commercialization of clinical trials matching tools, and surge in adoption of patient matching software. For instance, in April 2023, Metastatic Trial Search (MTS), a mobile-responsive version of Quantum Leap Healthcare Collaborative's (QLHC) metastatic breast cancer clinical trial matching engine, has been released. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to a vast patient pool readily accessible, patient recruitment processes are simplified, prompting numerous organizations to establish their research & development initiatives, uptick in the number of IT healthcare projects, and collaborations among key market players are on the rise. For instance, in November 2023, AstraZeneca unveils Evinova, positioned as a prominent supplier of digital health solutions aimed at enhancing the requirements of healthcare professionals, regulators, and patients. Supported by AstraZeneca's enduring commitment and strategic partnerships with Parexel and Fortrea, Evinova delivers globally-scalable digital offerings to the life sciences and healthcare industry.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Rising introduction of sophisticated clinical trial matching software is predicted to boost the market growth during the forecast period. Pharmaceutical manufacturers, biotechnology firms, clinical research organizations (CROs), and medical device manufacturers frequently conduct clinical trials to assess the safety and efficacy of new drugs, diagnostics, and therapies. With patient recruitment and matching being essential components of clinical trials, there's a growing trend of conducting these trials in developing regions where such resources are readily available. For instance, in September 2023, Belong.Life has introduced a novel artificial intelligence (AI) platform for matching cancer clinical trials, named Tara. This Software as a Service (SaaS) solution is accessible to hospitals, health systems, and contract research organizations (CROs). In order to match patients with appropriate clinical trials based on their eligibility and geography, Tara uses machine learning and natural language processing.
By deployment mode, web & cloud was the highest revenue-grossing segment in the global clinical trial matching software market in 2023 owing to the cloud computing concept, which offers powerful cloud-based solutions and is easy to operate with no maintenance costs. Development expenses are decreased since internal server infrastructure is not needed. It may be accessible from anywhere and has a far shorter integration period. Sharing data is easy and enables cooperation on many initiatives. For instance, in July 2022, The Advarra eRegulatory Management (eReg) system now offers an end-to-end Secure Document Exchange solution. Leading provider of clinical research technologies for sponsors and sites, regulatory review systems, and consulting services for research quality and compliance is Advarra. Additionally, on-premises is predicted to grow at the fastest CAGR during the forecast period owing to the approach necessitates longer integration periods, in-house infrastructure, software license, and IT support. Government and financial institutions, among other organizations, need to ensure the security and privacy of their on-premises environment since they handle highly secret data.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global clinical trial matching software market in 2023 owing to the huge amount of clinical trials needed before a product is introduced. Additionally, contract research organization (CRO) is expected to grow at the fastest CAGR during the forecast period. Software providers are developing innovative, cutting-edge techniques, while CROs provide drug development through commercialization, pharmacovigilance, and post-approval services to industrial businesses with limited R&D funds. For instance, in February 2022, The CTMA made CT-SCOUT technology more accessible in the field of rheumatology.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing uptake of clinical trials matching software among pharmaceutical & biotechnology firms, rising investment in the development of such software, favorable regulatory landscape conducive to the development & commercialization of clinical trials matching tools, and surge in adoption of patient matching software. For instance, in April 2023, Metastatic Trial Search (MTS), a mobile-responsive version of Quantum Leap Healthcare Collaborative's (QLHC) metastatic breast cancer clinical trial matching engine, has been released. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to a vast patient pool readily accessible, patient recruitment processes are simplified, prompting numerous organizations to establish their research & development initiatives, uptick in the number of IT healthcare projects, and collaborations among key market players are on the rise. For instance, in November 2023, AstraZeneca unveils Evinova, positioned as a prominent supplier of digital health solutions aimed at enhancing the requirements of healthcare professionals, regulators, and patients. Supported by AstraZeneca's enduring commitment and strategic partnerships with Parexel and Fortrea, Evinova delivers globally-scalable digital offerings to the life sciences and healthcare industry.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Deployment Mode and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Clinical Trial Matching Software Market Report 2023 - 2034
Clinical Trial Matching Software Market Analysis & Forecast by Deployment Mode 2023 - 2034 (Revenue USD Mn)
- On-premise
- Web & Cloud-based
Clinical Trial Matching Software Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- CROs
- Medical Device Firms
- Pharmaceutical & Biotechnology Companies
Clinical Trial Matching Software Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Clinical Trial Matching Software Market: Deployment Mode Estimates & Trend Analysis
8. Clinical Trial Matching Software Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Clinical Trial Matching Software Market
11. Europe Global Clinical Trial Matching Software Market
12. Asia Pacific Global Clinical Trial Matching Software Market
13. Latin America Global Clinical Trial Matching Software Market
14. MEA Global Clinical Trial Matching Software Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Aris Global
- Clinical Trials Mobile Application
- IBM Clinical development
- Advarra
- SSS International Clinical Research
- Antidote Technologies Inc.
- Ofni Systems
- Clario
- Microsoft Corporation
- Bsi Business Systems Integration AG
